. SAHH, an essential enzyme of the methylation cycle, is expressed by neural crest cells. (A) The methylation cycle. Methyltransferase-mediated transfer of a methyl group (CH 3 ) to a substrate (X) produces S-adenosylhomocysteine (SAH), which inhibits further methylation reactions. S-adenosylhomocysteine hydrolase (SAHH) hydrolyzes SAH, relieving the feedback inhibition. Tubercidin is a pharmacological SAHH inhibitor. (B-I) Neural crest cells express SAHH mRNA. Four-somite (4s, B-E) and nine-somite chick embryos (9s, F-I) sectioned at forebrain (C), midbrain (G), hindbrain (D and H), and trunk (E and I) levels. SAHH mRNA is widely expressed, but particularly abundant in cranial (C and D) and trunk (E and I) premigratory neural crest precursors (white arrowheads). Cranial neural crest cells maintain SAHH expression as they initiate migration (H), and migrate through the head mesenchyme (G; black arrowheads), expressing the neural crest marker HNK-1 (G, white arrow). (B and F) Dorsal view; (C-E and G-I) transverse section at the level indicated in the accompanying whole mount. nne, nonneural ectoderm; nt, neural tube. Bars: (B and F) 500 µm; (all other bars) 100 µm. Figure S2 . SAHH MO knocks down SAHH protein levels, but blocking SAHH does not alter cell death or proliferation. (A-C) SAHH MO-electroporated cells are deficient for SAHH protein. Embryos were unilaterally electroporated at late gastrula with SAHH MO and re-incubated to four somites (4s, A-A) or eight somites (8s, B-B and C). (A-B) In cross sections, SAHH immunoreactivity (red, A and B) is reduced in cells that have been targeted with SAHH MO (green, A and B; cells inside circle) compared with surrounding cells (cells outside circle). (C) In Western blots of dissected, electroporated neural folds, SAHH protein levels are reduced in SAHH MO-electroporated compared with CO MO-electroporated tissue. Residual SAHH protein in SAHH MOelectroporated sample is likely due to the mosaicism of electroporation (A and B) and/or perdurance of existing protein. GAPDH was used as a loading control. (D and E) SAHH knockdown does not lead to cell death. Embryos unilaterally electroporated with SAHH MO (green) at late gastrula and re-incubated to seven somites (7s) were sectioned and immunostained with anti-cleaved caspase 3 antibody (cl. casp3; red, D) and DAPI (nucleus; blue). The percentage of cl. casp3-positive cells is not significantly different on the targeted side of the embryo compared with the untargeted side (E; P = 0.07). (F and G) SAHH knockdown does not affect proliferation. Embryos unilaterally electroporated with SAHH MO (F, green) at late gastrula and re-incubated to seven somites (7s) were sectioned and immunostained with anti-phospho-histone H3 (pH3; red, F) and DAPI (nucleus; blue). The percentage of pH3-positive cells is not significantly different on the targeted side of the embryo compared with the untargeted side (G; P = 0.45). (H-L) Tubercidin inhibits neural crest migration in a dose-dependent manner, but does not cause cell death. (H-K) Neural tube explants were cultured in increasing concentrations of tubercidin (0.1-0.75 µM) and stained with HNK-1. Fewer HNK-1-positive neural crest cells migrate away from the neural tube with increasing concentration of tubercidin, showing dose dependency. (J) Bar graph depicting the ratio of TUNEL-positive cells to DAPI-positive cells surrounding the neural tube, showing that tubercidin does not alter the incidence of dying cells at 0.1, 0.25, 0.5, 0.75, and 1.0 µM compared with carrier treatment. Bars, 100 µm. Figure S4 . Exogenous SAHH rescues SAHH knockdown, showing SAHH MO is specific. Embryos were unilaterally electroporated with standard control MO (CO MO; A, green) or SAHH MO (B and C, green) mixed with empty pMES-mCherry expression vector (A and B, red) or pMES-mCherry driving SAHH (C, red) at late gastrula. Embryos were incubated to 8-9 somites (s), and neural crest cell migration was visualized by Sox10 in situ hybridization (purple). White arrowhead, targeted side of embryo; black arrowhead, untargeted side of embryo. (A-C) Representative embryos showing SAHH MO rescue. Neural crest migration is mildly disrupted on the targeted side when CO MO is unilaterally co-electroporated with empty pMES-mCherry (A), but is severely disrupted when SAHH MO is unilaterally co-electroporated with empty pMES-mCherry (B). Co-electroporation of SAHH MO along with 5 mg/ml pMES-SAHH-mCherry rescues SAHH knockdown so that neural crest cells migrate normally on the targeted side (C). (D) Stacked bar graph depicting the frequency and severity of migration defects in embryos co-electroporated with CO MO, SAHH MO, and pMES-mCherry expression constructs, showing that adding back SAHH rescues the migration phenotype compared with SAHH MO alone. The incidence of minimally affected control embryos may be higher than usual due to electroporation of large quantities of nucleic acid. Figure S5 . EF11-GFP and EF11-6xMM-GFP localization resembles endogenous EF11 and does not affect cell survival. Embryos were electroporated with EF11-GFP (EF11; A-C, green; A-C) or EF11-6xMM-GFP (EF11-6xMM or 6xMM; D-F, green; D-F) at late gastrula. (A-F) Localization of EF11 GFP fusions. Cranial neural folds from electroporated embryos were cultured and emigrating cells immunostained for HNK-1 (neural crest; red) and DAPI (nucleus; blue). EF11-GFP and EF11-6xMM-GFP localize in lamella (A, B, D, and E, white arrowheads) and filopodia (C and F, white arrowheads) like endogenous EF11 (Fig. 7) . (G) Cultured cranial neural crest cells that express methylation-resistant EF11 (EF11-6xMM) trend toward being less polarized than neural crest cells electroporated with empty vector (pMES) or wild-type EF11, though the effect is not statistically significant. (H-I) Methylationresistant EF11 does not cause cell death. EF11-6xMM-GFP-electroporated embryos were incubated to seven somites (7s). Transverse sections were immunostained with anti-cleaved caspase 3 (cl. casp3, H). (I) Bar graph depicting the percentage of cl. casp3-positive cells out of the total cells counted, showing that pMES, EF11-GFP, and EF11-6xMM-GFP do not significantly increase cell death on the targeted side of the embryo compared with the untargeted side (P = 0.19, EF1a1-6xMM). (J) EF11-6xMM-GFP-electroporated embryos were incubated to seven somites, and cadherin6B (Cad6B) (Iwabata et al., 2005) E, A Myosin-9 (myosin heavy chain 9) E, A Actin, alpha skeletal muscle (Iwabata et al., 2005) A Myosin-10 A Beta-actin (Iwabata et al., 2005) A Spectrin, alpha chain, brain A Tubulin-beta-7 chain A Tubulin-alpha-1 chain (Iwabata et al., 2005) A Tubulin beta-2 chain E, A Tubulin beta-5-chain A Myosin light polypeptide 6 E, A Myosin-11 E Elongation factor 1-alpha 1 (Ames and Niakido, 1979; Hiatt et al., 1982; Amons et al., 1983; Coppard et al., 1983; Toledo and Jerez, 1990) E, A (C) ATP/GTP synthesis ATP synthase subunit alpha, mitochondrial (Pang et al., 2010 (Nishioka et al., 2002) E, A Histone H2A.Z (Binda et al., 2013) E, A Histone H3.3 (Lachner et al., 2001) A 03 H1 protein A Histone H2.B (Gardner et al., 2011) E, A Table S1 . Putatively methylated proteins identified in a mass spectrometry proteomic screen (Continued)
Functional category/protein name Fraction
Predicted: similar to Rpl24 protein A Predicted: similar to ribosomal protein S15 isoform 2 A 60S ribosomal protein L27 (Pang et al., 2010) E, A Ribosomal protein L30 E, A 40S ribosomal protein S13 (Pang et al., 2010) A 40S ribosomal protein S11 E, A 40S ribosomal protein S14 E, A 60S ribosomal protein L36 (Carroll et al., 2008) E, A Predicted: similar to HL23 ribosomal protein E, A Predicted: similar to ribosomal protein S20 E, A 40S ribosomal protein S17 (Pang et al., 2010) A The results of proteomic analysis to identify neural crest cytoplasmic proteins containing mono-and di-methylated lysines. Proteins listed were identified by two or more peptides at 95% confidence. Proteins are classified into functional categories and labeled if they were identified from emigrating (E) or actively migrating (A) neural crest cells.
